AMERICAN CAPITAL MANAGEMENT INC - REPLIGEN CORP ownership

REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 505 filers reported holding REPLIGEN CORP in Q4 2021. The put-call ratio across all filers is 1.16 and the average weighting 0.2%.

Quarter-by-quarter ownership
AMERICAN CAPITAL MANAGEMENT INC ownership history of REPLIGEN CORP
ValueSharesWeighting
Q3 2023$36,301,824
+12.4%
228,299
-0.0%
1.40%
+24.7%
Q2 2023$32,309,605
+11.3%
228,401
+32.4%
1.12%
+9.8%
Q1 2023$29,041,595
+21.9%
172,497
+22.6%
1.02%
+9.5%
Q4 2022$23,830,552
+3.6%
140,751
+14.5%
0.93%
+2.8%
Q3 2022$23,000,000
+10.9%
122,924
-3.7%
0.91%
+16.9%
Q2 2022$20,736,000
-4.0%
127,687
+11.2%
0.78%
+22.0%
Q1 2022$21,595,000
-26.6%
114,814
+3.3%
0.64%
-15.7%
Q4 2021$29,437,000
-9.1%
111,152
-0.8%
0.76%
-13.0%
Q3 2021$32,370,000
+42.5%
112,010
-1.6%
0.87%
+36.6%
Q2 2021$22,723,000
+3.5%
113,829
+0.8%
0.64%
-4.2%
Q1 2021$21,949,000
+4.5%
112,899
+3.0%
0.66%
+5.7%
Q4 2020$21,006,000
+30.6%
109,618
+0.6%
0.63%
+6.3%
Q3 2020$16,082,000
+19.8%
109,002
+0.4%
0.59%
+19.6%
Q2 2020$13,421,000
+25.5%
108,579
-2.0%
0.49%
-5.0%
Q1 2020$10,696,000
+58.4%
110,789
+51.7%
0.52%
+83.7%
Q4 2019$6,754,000
+21.2%
73,015
+0.5%
0.28%
+14.6%
Q3 2019$5,573,000
-10.6%
72,665
+0.2%
0.25%
-7.5%
Q2 2019$6,232,000
+43.8%
72,510
-1.1%
0.27%
+32.8%
Q1 2019$4,333,000
+16.3%
73,340
+3.8%
0.20%
+1.0%
Q4 2018$3,727,000
-3.6%
70,675
+1.4%
0.20%
+17.8%
Q3 2018$3,866,00069,7150.17%
Other shareholders
REPLIGEN CORP shareholders Q4 2021
NameSharesValueWeighting ↓
12 West Capital Management LP 1,021,641$295,244,00013.47%
Ally Bridge Group (NY) LLC 70,000$20,229,0005.95%
Miura Global Management 85,000$24,564,0003.81%
Conestoga Capital Advisors, LLC 871,390$251,823,0003.48%
Ranger Investment Management 187,723$54,250,0002.90%
AWM Investment Company, Inc. 100,000$28,899,0002.84%
Brown Capital Management 1,017,477$294,041,0002.41%
Stephens Investment Management Group LLC 558,287$161,339,0002.19%
Yorktown Management & Research Co Inc 10,050$2,904,0002.18%
SV Health Investors, LLC 14,541$4,203,0002.06%
View complete list of REPLIGEN CORP shareholders